Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Comments for:

Editorial position on publishing articles on human organ transplantation
Arthur L. Caplan, … , Howard A. Rockman, Laurence A. Turka
Arthur L. Caplan, … , Howard A. Rockman, Laurence A. Turka
Published January 3, 2012
Citation Information: J Clin Invest. 2012;122(1):2-2. https://doi.org/10.1172/JCI61904.
View: Text | PDF
Editorial

Editorial position on publishing articles on human organ transplantation

  • Text
  • PDF
Abstract

The practice of transplanting organs from executed prisoners in China appears to be widespread. We vigorously condemn this practice and, effective immediately, will not consider manuscripts on human organ transplantation for publication unless appropriate non-coerced consent of the donor is provided and substantiated.

Authors

Arthur L. Caplan, Howard A. Rockman, Laurence A. Turka

×

Boycott of Chinese science and medicine pertaining to organ transplantation: Universal obligations to protect human rights

Submitter: Mohamed Y. Rady | Rady.Mohamed@mayo.edu

Authors: Michael Potts, Joseph L. Verheijde, David W. Evans, David J. Hill

Department of Critical Care Medicine, Mayo Clinic, Phoenix, Arizona 85054, USA

Published January 23, 2012

To the Editor

Caplan and colleagues (1) call for “boycott of Chinese science and medicine pertaining to organ transplantation” because of : “(1) use of executed prisoners as a source of organs, and (2) not all of the organs are provided by voluntary consenting donors.” In a roundtable discussion (2) of surgical extraction of vital organs from 3 infants for transplantation, Caplan concluded, correctly in our view, that the 3 infants were not dead at the time of surgical procurement. In that situation, valid donor consent was not obtained, and the process of procuring vital organs was the proximate cause of death. The parallels between “killing for organs” and absent “voluntary consent” of donors with the Chinese practice in organ donation should not be ignored. Both violate basic human rights and must be considered “morally reprehensible” (1). In civilized society, prisoners are considered “vulnerable persons” but so are dying adults and infants. Their basic human rights must be protected regardless of surrogate (parental) consent. Joffe and colleagues have highlighted unresolved practical problems in organ procurement. (3) In response to the Chinese organ procurement process, Caplan and colleagues (4) state that they “…vigorously condemn this practice and, effective immediately, will not consider manuscripts on human organ transplantation for publication unless appropriate non-coerced consent of the donor is provided and substantiated.” We agree with Caplan et al, but we think the boycott should apply to any organ procurement process based on an ethical system of recovery that implicitly allows for obtaining organs by “killing the donor” and “nonvoluntary consent/authorization.”

References

  1. Caplan AL, Danovitch G, Shapiro M, Lavee J, Epstein M. Time for a boycott of Chinese science and medicine pertaining to organ transplantation. Lancet. 2011;378(9798):1218.
  2. The New England Journal of Medicine (online). Perspective Roundtable: Organ Donation after Cardiac Death (Video Roundtable). 2008; http://content.nejm.org/cgi/content/full/359/7/669/DC1. Accessed 6 January, 2012.
  3. Joffe A, Carcillo J, Anton N, et al. Donation after cardiocirculatory death: a call for a moratorium pending full public disclosure and fully informed consent. Philos Ethics Humanit Med. 2011;6(1):17. http://www.peh-med.com/content/6/1/17.
  4. Caplan AL, Rockman HA, Turka LA. Editorial position on publishing articles on human organ transplantation. J Clin Invest. 2012;122(1):2-2.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts